Not a U.S. government website. NDD is an independent vulnerability database by Volerion and is not affiliated with or endorsed by NIST or NVD.
VOLERION
Volerion Security Research

NOT DEFERRED DATABASE

VULNERABILITIES

CVE-2017-17678 Details

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Metrics

CVSS 3.x Severity and Vector Strings:

References to Advisories, Solutions, and Tools

By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.

Weakness Enumeration

CWE-IDCWE NameSource
CWE-79Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')[email protected]

Affected Products

ProductVersions
bmc remedy mid-tier
9.1 sp3

CPE

  • cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*

Remediation

  • No remediation found in references.

Change History

7 change records found show changes


QUICK INFO

CVE Dictionary Entry:
CVE-2017-17678
NVD Published Date:
May 19, 2021
NVD Last Modified:
Jul 9, 2026
Source:
[email protected]
CVE-2017-17678 Details - Not Deferred